Research Article

Complex Inflammation mRNA-Related Response in ALS Is Region Dependent

Table 1

Summary of clinical and pathological data in the present series.

CasePathologySexAgeP-MRIN FCRIN SC

10M435 h 55 m8.16.5
20M474 h 55 m7.8
30M4615 h7.76
40F718 h 30 m7.46
50M523 h8.2
60M648 h 30 m7.7
70M675 h7.4
80F497 h8.2
90F753 h7.7
100F645 h7.1
11AD IIF864 h 15 m
12AD I F793 h 35 m
13AD I F796 h 25 m6.9
14AD IIF773 h 15 m
15AD IIF765 h 45 m
16AD I F5911 h 20 m6.9
17AD I M766 h 30 m6.8
18AD I M567 h 10 m 6.3
19AD IIM664 h 55 m6.4
20ALS/ADIF7613 h6.6
21ALSF5914 h 15 m6.5
22ALSM544 h 50 m7.7
23ALSM703 h7.27.2
24ALSM5610 h 50 m7.4
25ALSM774 h 30 m87.9
26ALS/AD IIF754 h 5 m7
27ALSF5710 h7.46.7
28ALSF563 h 45 m8.38.3
29ALS/AD IIM574 h6.5
30ALS/AD IIF792 h 10 m7.4
31ALSM6416 h 30 m7.47
32ALSM593 h 15 m7.87.5
33ALSF6313 h 50 m7.46.9

Thirty-three cases are analyzed corresponding to 19 controls and 14 amyotrophic lateral sclerosis (ALS) cases. Some ALS cases have concomitant AD-related pathology at stages I-II of Braak (AD I-II), and for this reason some control cases with similar stages of AD-related pathology are included in the study of the anterior lumbar spinal cord. However, only cases without AD-related pathology are selected for study in the frontal cortex area 8 (see text). M: male; F: female; P-M: postmortem delay (hours, minutes); FC: frontal cortex area 8; SC: anterior lumbar spinal cord; RIN: RNA integrity number.